Cas:13524-76-0 3,3-dimethyl-1-benzofuran-2-one manufacturer & supplier

Chemical Name:3,3-dimethyl-1-benzofuran-2-one

CAS.NO:13524-76-0

Synonyms:2,3-Dihydro-3,3-dimethylbenzofuran-2-one;dimethyl-2(3H)-benzofuranone;3,3-Dimethyl-1-benzofuran-2(3H)-one;3,3-Dimethyl-3H-benzofuran-2-on;2(3H)-Benzofuranone,3,3-dimethyl;3,3-Dimethylbenzofuran-2(3H)-one;3,3-dimethyl-3H-benzofuran-2-one;3,3-Dimethyl-2(3H)-benzofuranone

Molecular Formula:C₁₀H₁₀O₂

Molecular Weight:162.18500

HS Code:2932209090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:229.1ºC at 760 mmHg

Density:1.122g/cm3

Index of Refraction:1.533

PSA:26.30000

Exact Mass:162.06800

LogP:1.88320

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,3-Dihydro-3,3-dimethylbenzofuran-2-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3,3-Dimethyl-2(3H)-benzofuranone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-Dihydro-3,3-dimethylbenzofuran-2-one Use and application,2(3H)-Benzofuranone,3,3-dimethyl technical grade,usp/ep/jp grade.

Related News: Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. 8-Methyl-4,4b,9-triaza-phenanthren-10-one manufacturers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 2,5-dimethyl-3,6-bis(tetradecylamino)cyclohexa-2,5-diene-1,4-dione suppliers In the trial, 362 eligible patients were randomised (1:1) and received a fixed-dose intravenous infusion of 300mg anifrolumab or placebo every four weeks. 7-(2′-Desoxy-β-D-erythro-pentofuranosyl)-3,7-dihydro-2-methylthio-4H-pyrrolo(2,3-d)pyrimidin-4-on vendor & factory.